Evidence map›Paper›PMID 20666583›Full record

ArticleAIDS research and human retroviruses2010

Analysis of HIV diversity using a high-resolution melting assay.

William I Towler, Maria M James, Stuart C Ray, Lei Wang, Deborah Donnell, Anthony Mwatha, Laura Guay, Clemensia Nakabiito, Philippa Musoke, J Brooks Jackson and 1 more

Abstract read
In one paragraph

Article in AIDS research and human retroviruses, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Development of a genotyping platform for SARS-CoV-2 variants using high-resolution melting analysis.Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy · 2021
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. How can we better identify early HIV infections?Current opinion in HIV and AIDS · 2015
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

William I TowlerJohns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.
Maria M James
Stuart C Ray
Lei Wang
Deborah Donnell
Anthony Mwatha
Laura Guay
Clemensia Nakabiito
Philippa Musoke
J Brooks Jackson
Susan H Eshleman

Funding

International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) GroupU01AI068632 · NIAID · SOCIAL AND SCIENTIFIC SYSTEMS, INC. · PI JACKSON, J BROOKS · 2006 to 2010
$109.7M
LC: HIV Prevention Trials Network - Laboratory Support for the SARS-CoV-2 Seroprevalence Study (CoVPN 5002)UM1AI068613 · NIAID · JOHNS HOPKINS UNIVERSITY · PI SUSAN H ESHLEMAN, Mark A Marzinke · 2011 to 2026
$100.2M
HPTN CENTRAL LABORATORYU01AI046745 · NIAID · JOHNS HOPKINS UNIVERSITY · PI JACKSON, JAY B · 2000 to 2005
$20.8M
HIV Prevention Trials Network: Network LaboratoryU01AI068613 · NIAID · JOHNS HOPKINS UNIVERSITY · PI ESHLEMAN, SUSAN H · 2006 to 2010
$16.5M
MU-JHU HPTU TRIAL SITE--UGANDAU01AI048054 · NIAID · JOHNS HOPKINS UNIVERSITY · PI GUAY, LAURA A · 2000 to 2006
$14.4M
Mechanisms of Hepatitis C Virus EvolutionR01DA024565 · NIDA · JOHNS HOPKINS UNIVERSITY · PI RAY, STUART C · 2007 to 2011
$2.6M
STATISTICAL &CLINICAL COORDINATING CENTER (SC)N01AI045200 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI SELF, STEVEN G. · 1994 to 2000
$853k
INTNL.VACC.EFFICACY TRIALS MASTER CONTRACT (IMC)N01AI035173 · NIAID · FAMILY HEALTH INTERNATIONAL · PI CATES, WILLARD · 1993 to 2000
$0k
NIAID NIH HHS N01-AI-035173NIAID NIH HHS N01-AI-045200NIAID NIH HHS N0I-AI-035173-417NIAID NIH HHS U01-AI-046745NIAID NIH HHS U01-AI-048054NIAID NIH HHS U01 AI068613NIAID NIH HHS U01-AI-068613NIAID NIH HHS U01-AI-068632NIDA NIH HHS R01 DA024565
6 · The paper itself

Abstract

HIV viruses are usually genetically homogeneous shortly after infection, and become more heterogeneous over time. We developed a high-resolution melting (HRM) assay to analyze HIV diversity without sequencing. Plasma samples from the HIVNET 012 trial were obtained from nine Ugandan mother-infant pairs. DNA amplified from the HIV gag region was analyzed to determine the number of degrees over which the DNA melted (HRM score). HRM gag DNA was also cloned and sequenced (50 clones/mother; 20 clones/infant). The median HRM score for infants (4.3, range 4.2-5.3) was higher than that for control plasmids (3.4, range 3.2-3.8, p < 0.001) and lower than that for mothers (5.7, range 4.4-7.7, p = 0.005, exact Wilcoxon rank sum test). The intraclass correlation coefficient reflecting assay reproducibility was 94% (95% CI: 89-98%). HRM scores were also compared to sequenced-based measures of HIV diversity; higher HRM scores were associated with higher genetic diversity (p < 0.001), complexity (p = 0.009), and Shannon entropy (p = 0.022), but not with length variation (p = 0.111). The HRM assay provides a novel, rapid method for assessing HIV diversity without sequencing. This assay could be applied to any region of the HIV genome or to other genetic systems that exhibit DNA diversity.

Indexed as

Genetic VariationGenome, ViralNucleic Acid DenaturationDNA, ViralFemaleHIVHIV InfectionsHumansInfantUgandaDNA, Viral

Identifiers

PMID20666583
PMCPMC2920076

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.